IPF develops when the lungs become damaged or scarred, making it difficult to breathe. Researchers have long been searching for a better mechanistic understanding of IPF that could lead to better treatment.
A development program for junior faculty, LAMP provides participants with critical tools to accomplish their primary career goals as academicians in the field of medicine.
In her new role, Dr. Zappetti will be focused on advancing ambulatory programs across the WDOM, working to ensure the best use of space and resources to meet the growing needs of patients at WCM and NYP.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 17.
Until a vaccine is discovered and implemented for COVID-19, WDOM physicians on the frontlines continue to focus on diagnosis, drug treatment options, and best practices.
In response to the COVID-19 pandemic, faculty from across the Weill Department of Medicine have been pursuing critical research.
Funded by a $22 million grant from the National Institutes of Health and Three Lakes Partners, the PRECISIONS study aims to transform diagnosis and treatment for idiopathic pulmonary fibrosis.
A tribute to Dr. King’s legacy was held on October 2, 2019 at the Griffis Faculty Club as part of the division’s Briscoe-King Lung Club.
The treatment represents a major advancement in the management of individuals with COPD because it is the first minimally invasive procedure to help emphysema sufferers breathe better without major surgery.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 19.
